Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$148K Buy
1,630
+576
+55% +$52.6K 0.06% 264
2026
Q1
$108K Sell
1,054
-1
-0.1% -$113 0.05% 263
2025
Q4
$132K Sell
1,055
-328
-24% -$41.8K 0.07% 230
2025
Q3
$185K Sell
1,383
-1,227
-47% -$161K 0.07% 225
2025
Q2
$349K Sell
2,610
-2,089
-44% -$275K 0.18% 111
2025
Q1
$623K Buy
4,699
+142
+3% +$18.1K 0.25% 86
2024
Q4
$583K Buy
+4,557
New +$527K 0.27% 79

Other funds holding ABT

AmeriFlex Group's ABT Position: Q2 2026 in Review

AmeriFlex Group increased its Abbott (ABT) stake by 55% in Q2 2026, buying an estimated $52.6K and bringing the position to 1,630 shares worth $148K. The position accounts for 0.06% of the portfolio, ranked #264.

AmeriFlex Group first reported a position in ABT in Q4 2024 and has held it in 7 quarters since. The position peaked at $623K in Q1 2025. 2,968 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • AmeriFlex Group held 1,630 shares of Abbott worth $148K as of Q2 2026.
  • AmeriFlex Group bought 576 Abbott shares in Q2 2026, an estimated $52.6K.
  • Abbott made up 0.06% of AmeriFlex Group's portfolio in Q2 2026, its #264 holding.
  • AmeriFlex Group first reported a position in Abbott in Q4 2024 and has held it in 7 quarters since.
  • AmeriFlex Group's Abbott position peaked at $623K in Q1 2025.
  • 2,968 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.